Skip to main content

Series B Biotechnology Companies

Explore 428 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
428
Total Funding
$1.8B
Avg Funding
$71.9M
Cities
20

Export 428 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Francisco, United States
$1.0M
raised

Amfora is a biotech start-up with a focus on developing crops with enhanced nutritional content.

Jul 2021
Series B

Founder Contacts

30,000+ verified contacts

San Mateo, United States
$75.0M
raised

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

Jul 2022
Series B

Founder Contacts

30,000+ verified contacts

Boston, United States
$60.3M
raised

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

Jul 2024
Series B

Founder Contacts

30,000+ verified contacts

Palo Alto, United States
$225.0M
raised

DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.

Jul 2022
Series B

Founder Contacts

30,000+ verified contacts

White Plains, United States
$15.0M
raised

Retia is medical device company that develops and sells software and hardware for patient monitoring.

Jul 2022
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 428 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$260.0M
raised

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

Jul 2024
Series B

Founder Contacts

30,000+ verified contacts

Irvine, United States
$118.0M
raised

Helio Health is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw.

Jul 2021
Series B

Founder Contacts

30,000+ verified contacts

Seattle, United States
$112.0M
raised

A biotechnology company developing RNA technologies to shape the future of gene therapy

Jul 2021
Series B

Founder Contacts

30,000+ verified contacts

Foster City, United States
$189K
raised

Notable Labs provides personalized drug combination testing service for cancer patients.

Jul 2022
Series B

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$150.0M
raised

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Jul 2023
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 428 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Bethesda, United States
$12.0M
raised

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

Jun 2023
Series B

Founder Contacts

30,000+ verified contacts

New York, United States
$31.5M
raised

AgNovos is a regenerative technology that restores the structure and biomechanics of bone to transform the paradigm of care for osteoporosis

Jun 2023
Series B

Founder Contacts

30,000+ verified contacts

Boston, United States
$20.0M
raised

NFlection Therapeutics is a biopharmaceutical company focusing on targeted treatments for rare diseases.

Jun 2022
Series B

Founder Contacts

30,000+ verified contacts

Waltham, United States
$200.0M
raised

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Jun 2023
Series B

Founder Contacts

30,000+ verified contacts

La Jolla, United States
$44.9M
raised

Singlera Genomics is a fast growing company focusing on non-invasive genetic testing.

Jun 2022
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 428 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Tokyo, Japan
$29.2M
raised

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

Jun 2022
Series B

Founder Contacts

30,000+ verified contacts

Tokyo, Japan

OriCiro Genomics develops and commercializes cell-free synthesis and amplification technologies of large DNA molecules.

Jun 2022
Series B

Founder Contacts

30,000+ verified contacts

Barcelona, Spain
$86.6M
raised

Ona Therapeutics develops antibody-drug conjugates and therapies for the treatment of advanced and treatment-resistant cancers.

Jun 2026
Series B

Founder Contacts

30,000+ verified contacts

$32.8M
raised

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Jun 2026
Series B

Founder Contacts

30,000+ verified contacts

Breda, The Netherlands
$20.5M
raised

The Protein Brewery specializes in developing and making animal-free-based protein in a sustainable way.

Jun 2026
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 428 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Oxford, United Kingdom
$97.0M
raised

MiroBio is Harnessing the natural control mechanisms of the immune system.

Jun 2022
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$70.0M
raised

K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.

Jun 2023
Series B

Founder Contacts

30,000+ verified contacts

Singapore, Singapore
$41.6M
raised

Lion TCR is a clinical-stage biotechnology company.

Jun 2023
Series B

Founder Contacts

30,000+ verified contacts

Cleveland, United States
$33.0M
raised

Centerline Biomedical, a Cleveland Clinic spin-off, is developing an innovative system

Jun 2022
Series B

Founder Contacts

30,000+ verified contacts

Oakland, United States
$62.0M
raised

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

Jun 2026
Series B

Founder Contacts

30,000+ verified contacts

Showing 51 to 75 of 428 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 428 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked